neoepitopes class major histocompatibility complex mhc bounded represent antigenic determinants neoantigens neoepitopes recognized immune system targets cells elicit immune response epitopes also referred antigenic determinants parts antigen recognized immune system neoepitope epitope immune system encountered therefore subject tolerance mechanisms immune mutant gene product expressed tumors found noncancerous cells neoepitopes may evoke vigorous cell tumor mutational burden tmb number mutations within targeted genetic region cancerous cells dna correlates number neoepitopes suggested correlate patient survival post immunotherapy although findings neoantigenimmunogenicity association neoepitopes arise posttranslational modifications mrna translates information dna polypeptide composed standard amino acids proteins several standard amino acids posttranslationally modified enzymatic processes altered spontaneous nonenzymatic biochemical increasing evidence immune recognition neoepitopes produced cancerspecific mutations key mechanism induction immunemediated tumor rejection opportunities therapeutic targeting cancer specific neoepitopes cancer patientspecific disease two tumors alike thus immunogenicity tumor novel strategy cancer epitope selection mutanomedirected individualized cancer individualized cancer immunotherapy leverages adaptive immune system targeting cells tumor cells tumor specific mutant antigen neoantigen neoepitopes recognized receptor one challenge identify neoepitopes trigger suitable immune response find neoepitopes individual tumor highly individualized cancer immunotherapy includes vaccination tumor mutationderived neoepitopes concept based mapping tumorspecific individual mutanome identification range suitable neoepitopes patientspecific expected neoepitopes vaccine trigger cell responses specific cancer concept individualized cancer vaccination first data httpsenwikipediaorgwikineoepitope